Nov SEC Filings

Type
Report
Date
SCHEDULE 13G/ASCHEDULE 13G/A-Formular3/27/2026
4Insidertransaktion3/24/2026
4Insidertransaktion3/24/2026
4Insidertransaktion3/24/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/18/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/25/2026
4Insidertransaktion2/24/2026
4Insidertransaktion2/24/2026
144144-Formular2/23/2026
144144-Formular2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/23/2026
4Insidertransaktion2/20/2026
4Insidertransaktion2/20/2026
4Insidertransaktion2/20/2026
4Insidertransaktion2/20/2026
4Insidertransaktion2/20/2026
4Insidertransaktion2/20/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/20/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/17/2026
10-KJahresbericht2/12/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
4Insidertransaktion2/9/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/5/2026
4Insidertransaktion11/24/2025
4Insidertransaktion11/24/2025
4Insidertransaktion11/24/2025
4Insidertransaktion11/24/2025
144144-Formular11/24/2025
144144-Formular11/24/2025
144144-Formular11/24/2025
144144-Formular11/24/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/20/2025
10-QQuartalsbericht10/28/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/28/2025
SCHEDULE 13GSCHEDULE 13G-Formular10/9/2025
10-QQuartalsbericht7/29/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/29/2025
11-K11-K-Formular6/26/2025
SDSD-Formular5/30/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
4Insidertransaktion5/22/2025
S-8S-8-Formular5/20/2025
10-QQuartalsbericht4/29/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/29/2025
ARSARS-Formular4/9/2025
DEFA14ADEFA14A-Formular4/9/2025
DEF 14ADEF 14A-Formular4/9/2025
4Insidertransaktion3/24/2025
4Insidertransaktion3/24/2025
4Insidertransaktion3/24/2025
33-Formular3/20/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/20/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular3/5/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/24/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/21/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
10-KJahresbericht2/14/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025
4Insidertransaktion2/7/2025

Nov Documents 2026

This page contains all official documents and SEC filings for Nov stock (NOV, ISIN: US62955J1034). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Nov's regulatory filings.

Nov Stock analysis

Nov Nov Inc is a globally operating company that was founded in the USA in 1976. The company specializes in the development and manufacture of products in various fields, including pharmaceuticals, biotechnology, agrochemicals, and electronics. Nov Inc's business model is based on the research and development of new technologies and products. The company invests a significant portion of its resources in the research and development of new drugs and technologies. Nov Inc works closely with scientific organizations and universities to achieve this. The goal of Nov Inc is to develop products that have a positive impact on health, science, and the environment. The company aims to improve the quality of life for people worldwide by developing innovative products that meet the needs of its customers. Nov Inc is divided into several divisions. The main divisions are pharmaceuticals, biotechnology, diagnostics, crop protection, and electronics. In each of these divisions, the company produces products tailored to the needs of its customers. In the pharmaceutical field, Nov Inc develops and produces drugs for the treatment of various diseases such as cancer, diabetes, and cardiovascular diseases. Nov Inc's products are well-known worldwide and are taken by millions of patients every day. The company is proud to make a significant contribution to improving the health of people worldwide. In the biotechnology division, Nov Inc develops products for use in agriculture and environmental protection. This includes improved seed varieties that are more resistant to insects and diseases, thus reducing the use of pesticides. Nov Inc also produces biological pesticides that protect plants from pests while being non-toxic and environmentally friendly. In the diagnostics division, Nov Inc develops and produces tests for the diagnosis of infectious diseases and other medical conditions. These tests are important for the timely detection of diseases and enable early treatment. In the electronics division, Nov Inc develops and produces electronic devices and components. This includes semiconductors, sensors, and displays. These components are used in various industries, including telecommunications, automotive, and aerospace. In addition to the above-mentioned divisions, Nov Inc also offers other products, including food additives, colorants, fragrances, and chemicals for industrial use. Overall, Nov Inc has made a significant contribution to improving health, science, and the environment over the past decades. The company is globally recognized for its innovative products and technologies and will remain an important player in research and development in the future.